The global Syndromic Multiplex Diagnostic Market in 2026 is at the forefront of precision medicine. Moving away from traditional "one-test, one-pathogen" protocols, healthcare providers are increasingly adopting a "symptoms-first" approach. This allow clinicians to test for a broad panel of potential viral, bacterial, and fungal culprits simultaneously, drastically reducing the "diagn... https://www.databridgemarketresearch.com/